Haleon names Jo Cooper as new general manager for UK & Ireland
She was previously the supplier's head of commercial excellence for Europe, Middle East, Africa & Latin America ...
pharmaphorum1d
EU approves endometrial, lung cancer drugs from GSK and J&J
Meanwhile, J&J has claimed EU approval for its combination of EGFRxMET bispecific antibody Rybrevant (amivantamab) with third ...
Pharmaceutical Technology1d
EC approves GSK’s Jemperli-chemo combo for endometrial cancer
The EC has approved GSK's Jemperli (dostarlimab) combined with chemotherapy for primary advanced or recurrent endometrial cancer in adults.
Is GSK plc (GSK) an Undervalued Defensive Stock for 2025?
We recently published a list of 12 Undervalued Defensive Stocks for 2025. In this article, we are going to take a look at ...
GlaxoSmithKline: Sell Rating Amidst Weak Vaccine Performance and Projected EPS Decline
GlaxoSmithKline (GSK – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Graham Parry from ...
GlaxoSmithKline (GSK) Receives a Hold from Jefferies
Jefferies analyst Peter Welford maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £14.50. The ...
Is GSK plc (GSK) One of the Cheapest Stocks with Biggest Upside Potential?
We recently compiled a list of the 12 Cheapest Stocks with Biggest Upside Potential. In this article, we are going to take a ...